ArticleFrontiers in immunology2026

Case Report: Upadacitinib and apremilast combination therapy for guselkumab-induced paradoxical eczema in psoriasis.

Luan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.